| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 10/17/2023 | -4.48% | Wells Fargo | $48 → $47 | Maintains | Equal-Weight |
| 10/10/2023 | 7.71% | Barclays | $52 → $53 | Maintains | Equal-Weight |
| 10/02/2023 | 1.62% | Piper Sandler | $55 → $50 | Maintains | Neutral |
| 09/21/2023 | -12.61% | Goldman Sachs | $47 → $43 | Downgrades | Neutral → Sell |
| 09/14/2023 | 9.74% | Jefferies | $46 → $54 | Maintains | Hold |
| 08/18/2023 | 11.78% | Morgan Stanley | $53 → $55 | Maintains | Equal-Weight |
| 08/09/2023 | 7.71% | Morgan Stanley | $52 → $53 | Maintains | Equal-Weight |
| 07/17/2023 | -2.45% | Wells Fargo | $43 → $48 | Maintains | Equal-Weight |
| 07/11/2023 | -0.42% | Barclays | $42 → $49 | Maintains | Equal-Weight |
| 07/07/2023 | 1.62% | Piper Sandler | $44 → $50 | Maintains | Neutral |
| 06/09/2023 | 15.84% | Keefe, Bruyette & Woods | $62 → $57 | Maintains | Market Perform |
| 06/02/2023 | 5.68% | Morgan Stanley | $53 → $52 | Maintains | Equal-Weight |
| 05/15/2023 | -12.61% | Wells Fargo | $46 → $43 | Maintains | Equal-Weight |
| 05/10/2023 | -10.58% | Piper Sandler | $46 → $44 | Maintains | Neutral |
| 05/10/2023 | -14.64% | Barclays | $46 → $42 | Maintains | Equal-Weight |
| 04/12/2023 | -6.51% | Barclays | $58 → $46 | Maintains | Equal-Weight |
| 04/12/2023 | 7.71% | Morgan Stanley | $64 → $53 | Maintains | Equal-Weight |
| 04/05/2023 | -6.51% | Piper Sandler | $56 → $46 | Maintains | Neutral |
| 04/05/2023 | 1.62% | Goldman Sachs | $61 → $50 | Maintains | Neutral |
| 02/24/2023 | 30.07% | Morgan Stanley | $65 → $64 | Maintains | Equal-Weight |
| 02/21/2023 | 21.94% | Jefferies | $55 → $60 | Maintains | Hold |
| 02/13/2023 | 15.84% | Wells Fargo | $53 → $57 | Maintains | Equal-Weight |
| 02/08/2023 | — | Raymond James | Initiates Coverage On | → Market Perform | |
| 01/18/2023 | 7.71% | Wells Fargo | $52 → $53 | Maintains | Equal-Weight |
| 01/10/2023 | 32.1% | Morgan Stanley | $59 → $65 | Maintains | Equal-Weight |
| 01/10/2023 | 9.74% | Barclays | $47 → $54 | Maintains | Equal-Weight |
| 12/20/2022 | 9.74% | Piper Sandler | $55 → $54 | Maintains | Neutral |
| 11/17/2022 | 19.91% | Morgan Stanley | $58 → $59 | Maintains | Equal-Weight |
| 10/14/2022 | -4.48% | Barclays | $45 → $47 | Maintains | Equal-Weight |
| 10/12/2022 | -0.42% | Wells Fargo | $51 → $49 | Maintains | Equal-Weight |
| 08/17/2022 | 17.87% | Morgan Stanley | $54 → $58 | Maintains | Equal-Weight |
| 08/08/2022 | -8.55% | Barclays | $44 → $45 | Maintains | Equal-Weight |
| 07/14/2022 | -10.58% | Barclays | $55 → $44 | Maintains | Equal-Weight |
| 07/08/2022 | -12.61% | Piper Sandler | $50 → $43 | Maintains | Neutral |
| 07/06/2022 | 5.68% | Evercore ISI Group | $57 → $52 | Maintains | In-Line |
| 07/06/2022 | 9.74% | Morgan Stanley | $62 → $54 | Maintains | Equal-Weight |
| 05/27/2022 | 1.62% | Piper Sandler | $47 → $50 | Maintains | Neutral |
| 05/10/2022 | 26% | Morgan Stanley | $64 → $62 | Maintains | Equal-Weight |
| 04/12/2022 | 11.78% | Barclays | $61 → $55 | Maintains | Equal-Weight |
| 04/12/2022 | 9.74% | Wells Fargo | → $54 | Upgrades | Underweight → Equal-Weight |
| 04/08/2022 | 30.07% | Morgan Stanley | $65 → $64 | Maintains | Equal-Weight |
| 04/06/2022 | 11.78% | Piper Sandler | $65 → $55 | Maintains | Neutral |
| 04/05/2022 | 28.04% | Goldman Sachs | $55 → $63 | Maintains | Neutral |
| 02/22/2022 | 32.1% | Morgan Stanley | $62 → $65 | Maintains | Equal-Weight |
| 02/11/2022 | 26% | Morgan Stanley | $60 → $62 | Maintains | Equal-Weight |
| 01/21/2022 | 60.55% | Wolfe Research | → $79 | Initiates Coverage On | → Outperform |
| 01/11/2022 | 13.81% | Barclays | $54 → $56 | Upgrades | Underweight → Equal-Weight |
| 01/07/2022 | 21.94% | Morgan Stanley | $56 → $60 | Maintains | Equal-Weight |
| 01/05/2022 | 15.84% | Evercore ISI Group | $62 → $57 | Downgrades | Outperform → In-Line |
| 11/09/2021 | 9.74% | Barclays | $47 → $54 | Maintains | Underweight |
| 11/08/2021 | 11.78% | RBC Capital | $50 → $55 | Maintains | Sector Perform |
| 10/14/2021 | 11.78% | Morgan Stanley | $53 → $55 | Maintains | Equal-Weight |
| 08/09/2021 | 1.62% | RBC Capital | $46 → $50 | Maintains | Sector Perform |
| 08/09/2021 | -4.48% | Barclays | $42 → $47 | Maintains | Underweight |
| 08/09/2021 | -4.48% | Wells Fargo | $45 → $47 | Maintains | Underweight |
| 07/15/2021 | 7.71% | Morgan Stanley | $52 → $53 | Maintains | Equal-Weight |
| 05/19/2021 | 5.68% | Morgan Stanley | $50 → $52 | Maintains | Equal-Weight |
| 05/11/2021 | 1.62% | Morgan Stanley | $48 → $50 | Maintains | Equal-Weight |
| 04/01/2021 | -2.45% | Morgan Stanley | $45 → $48 | Maintains | Equal-Weight |
| 03/31/2021 | -6.51% | Citigroup | $35 → $46 | Upgrades | Sell → Neutral |
| 03/17/2021 | -14.64% | Credit Suisse | $36 → $42 | Maintains | Neutral |
| 02/25/2021 | -8.55% | Morgan Stanley | $43 → $45 | Maintains | Equal-Weight |
| 02/11/2021 | -12.61% | Morgan Stanley | $41 → $43 | Maintains | Equal-Weight |
| 01/15/2021 | -16.68% | Morgan Stanley | $36 → $41 | Maintains | Equal-Weight |
| 11/18/2020 | -26.84% | Morgan Stanley | $32 → $36 | Maintains | Equal-Weight |
| 11/06/2020 | -34.97% | Morgan Stanley | $30 → $32 | Maintains | Equal-Weight |
| 10/06/2020 | -39.03% | Morgan Stanley | $28 → $30 | Maintains | Overweight |
| 08/20/2020 | -43.1% | Morgan Stanley | $27 → $28 | Maintains | Equal-Weight |
| 08/10/2020 | -45.13% | Morgan Stanley | $28 → $27 | Maintains | Equal-Weight |
| 07/06/2020 | -43.1% | Morgan Stanley | $26 → $28 | Maintains | Equal-Weight |
| 07/02/2020 | -43.1% | Piper Sandler | $33 → $28 | Maintains | Neutral |
| 06/18/2020 | -24.8% | Goldman Sachs | $38 → $37 | Downgrades | Buy → Neutral |
| 04/27/2020 | -30.9% | Credit Suisse | $45 → $34 | Maintains | Neutral |
| 04/01/2020 | -41.06% | Wells Fargo | $37 → $29 | Maintains | Underweight |
| 03/17/2020 | -47.16% | Morgan Stanley | $42 → $26 | Maintains | Equal-Weight |
| 03/10/2020 | -45.13% | Piper Sandler | $38 → $27 | Maintains | Neutral |
| 02/14/2020 | 15.84% | Goldman Sachs | $42 → $57 | Upgrades | Neutral → Buy |
| 01/23/2020 | -8.55% | B of A Securities | $42 → $45 | Maintains | Neutral |
| 01/08/2020 | — | Goldman Sachs | Upgrades | Sell → Neutral | |
| 01/06/2020 | -18.71% | Wells Fargo | → $40 | Downgrades | Equal-Weight → Underweight |
| 01/03/2020 | -30.9% | Credit Suisse | → $34 | Upgrades | Underperform → Neutral |
| 09/13/2019 | -32.93% | Citigroup | $36 → $33 | Maintains | Sell |
| 08/20/2019 | -16.68% | Morgan Stanley | $43 → $41 | Maintains | Equal-Weight |
| 08/06/2019 | -22.77% | B of A Securities | $42 → $38 | Reiterates | → Neutral |
| 07/10/2019 | -12.61% | Morgan Stanley | $46 → $43 | Maintains | Equal-Weight |
| 06/25/2019 | -34.97% | Goldman Sachs | $39 → $32 | Downgrades | Neutral → Sell |
| 06/25/2019 | -55.29% | Credit Suisse | $35 → $22 | Downgrades | Neutral → Underperform |
| 04/09/2019 | -18.71% | UBS | $37 → $40 | Maintains | Neutral |
| 04/04/2019 | -28.87% | Citigroup | $39 → $35 | Downgrades | Neutral → Sell |
| 11/06/2018 | 11.78% | Morgan Stanley | $58 → $55 | Maintains | Equal-Weight |
What is the target price for Brighthouse Finl (BHF)?
The latest price target for Brighthouse Finl (NASDAQ: BHF) was reported by Wells Fargo on October 17, 2023. The analyst firm set a price target for $47.00 expecting BHF to fall to within 12 months (a possible -4.48% downside). 28 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Brighthouse Finl (BHF)?
The latest analyst rating for Brighthouse Finl (NASDAQ: BHF) was provided by Wells Fargo, and Brighthouse Finl maintained their equal-weight rating.
When is the next analyst rating going to be posted or updated for Brighthouse Finl (BHF)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Brighthouse Finl, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Brighthouse Finl was filed on October 17, 2023 so you should expect the next rating to be made available sometime around October 17, 2024.
Is the Analyst Rating Brighthouse Finl (BHF) correct?
While ratings are subjective and will change, the latest Brighthouse Finl (BHF) rating was a maintained with a price target of $48.00 to $47.00. The current price Brighthouse Finl (BHF) is trading at is $49.21, which is out of the analyst's predicted range.